# Conversion Study From Cyclosporine to FK506MR Based Immunosuppression in Kidney Transplant Subjects

> **NCT00481481** · PHASE3 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 346 (actual)

## Conditions studied

- Transplantation

## Interventions

- **DRUG:** tacrolimus

## Key facts

- **NCT ID:** NCT00481481
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2009-04
- **Final completion:** 2009-04
- **Target enrollment:** 346 (ACTUAL)
- **Last updated:** 2014-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00481481

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00481481, "Conversion Study From Cyclosporine to FK506MR Based Immunosuppression in Kidney Transplant Subjects". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00481481. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*